Cancer Colon Therapy

LONDON and DENVER, June 29 /PRNewswire/ -- On July 12, a one-day symposium, hosted by the Royal Veterinary College and Morris Animal Foundation, will address the number one cause of death in dogs over the age of two -- cancer -- as well as "translational" cancer treatment research, where the same treatments being developed to help dogs suffering from cancer are being successfully applied to humans, especially children. This is the single most intensive, dedicated event related to this subject ever undertaken in the United Kingdom.

U.S.-based, Morris Animal Foundation (MAF) will announce its Cure Canine Cancer Campaign to the United Kingdom. One in four dogs in the UK and worldwide die of cancer; many more suffer its devastating effects. "With canine (comparative) cancer research being a major part of RVC's future Clinical Research Strategy and looking to help coordinate other critical cancer research efforts in the UK and worldwide, we are excited to be host of this very important and valuable MAF cancer research symposium," says Professor Jonathan Elliott, vice principal -- research, Royal Veterinary College.

Wildlife Returning To Chernobyl

The wilderness is encroaching over abandoned towns in the Chernobyl exclusion zone. One of the elderly residents who refused to evacuate the contaminated area says packs of wolves have eaten two of her dogs, and wild boar trample through her cornfield. Scientist are divided as to whether or not the animals are flourishing in the highly radioactive environment: "Robert J. Baker of Texas Tech University says the mice and other rodents he has studied at Chernobyl since the early 1990s have shown remarkable tolerance for elevated radiation levels. But Timothy Mousseau of the University of South Carolina, a biologist who studies barn swallows at Chernobyl, says that while wild animals have settled in the area, they have struggled to build new populations." .

Pilot Ginseng Study Shows Reduction In Cancer-Related Fatigue

North Central Cancer Treatment Group (http://ncctg/) (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn., have generated preliminary data suggesting that a form of American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment.

The results of their scientifically rigorous pilot study, the first to evaluate the Wisconsin species of American ginseng as a possible therapy for cancer-related fatigue, were presented at the annual meeting of the American Society of Clinical Oncology.

Many cancer patients face extreme fatigue after diagnosis and during treatment. Getting more sleep or rest often does not relieve the fatigue, nor is it related to activity levels.